These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2861224)

  • 21. Management of psychopharmacologic agents in children and adolescents.
    Carlson GA; Ranade L; Qadir A
    Psychiatr Q; 1992; 63(4):391-411. PubMed ID: 1361998
    [No Abstract]   [Full Text] [Related]  

  • 22. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory.
    Farmer CA; Epstein JN; Findling RL; Gadow KD; Arnold LE; Kipp H; Kolko DJ; Butter E; Schneider J; Bukstein OG; McNamara NK; Molina BS; Aman MG
    J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):117-124. PubMed ID: 27348211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tourette disorder.
    Zinner SH
    Pediatr Rev; 2000 Nov; 21(11):372-83. PubMed ID: 11077021
    [No Abstract]   [Full Text] [Related]  

  • 24. Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports.
    Brown TE
    J Child Adolesc Psychopharmacol; 2004; 14(1):129-36. PubMed ID: 15142400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive effects of psychostimulant medication in hyperactive children.
    Everett J; Thomas J; Cote F; Levesque J; Michaud D
    Child Psychiatry Hum Dev; 1991; 22(2):79-87. PubMed ID: 1686856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring psychostimulant side effects in hyperactive children.
    Golinko BE
    Drug Intell Clin Pharm; 1984 Apr; 18(4):324. PubMed ID: 6143650
    [No Abstract]   [Full Text] [Related]  

  • 27. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attention deficit hyperactivity disorder erroneously diagnosed and treated as bipolar disorder.
    Atmaca M; Ozler S; Topuz M; Goldstein S
    J Atten Disord; 2009 Sep; 13(2):197-8. PubMed ID: 19380515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ADD psychosis: treatment with antipsychotics and methylphenidate?].
    Blom JD; Kooij JJ
    Tijdschr Psychiatr; 2012; 54(1):89-93. PubMed ID: 22237615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulants, neuroleptics, and children's friendship training for children with fetal alcohol spectrum disorders.
    Frankel F; Paley B; Marquardt R; O'Connor M
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):777-89. PubMed ID: 17201621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From the Editor-in-Chief's Desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):601. PubMed ID: 26485085
    [No Abstract]   [Full Text] [Related]  

  • 32. [Attention-deficit/hyperactivity disorder. Clinical and treatment aspects].
    Diaconu G; Grigore I; Burlea M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):656-62. PubMed ID: 20191811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract]   [Full Text] [Related]  

  • 34. Broader clinical considerations in child psychopharmacology practice.
    Safer DJ
    Compr Psychiatry; 1983; 24(6):567-73. PubMed ID: 6140125
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacotherapy of attention-deficit/hyperactivity disorder (ADHD) and comorbid disorders].
    Wiesegger G; Kienbacher C; Pellegrini E; Scheidinger H; Vesely C; Bangerl W; Friedrich M
    Neuropsychiatr; 2007; 21(3):187-206. PubMed ID: 17915180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recognition and treatment of attention deficit disorder.
    Bond WS
    Clin Pharm; 1987 Aug; 6(8):617-24. PubMed ID: 2891464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined stimulant and antipsychotic treatment in adolescents with attention-deficit/hyperactivity disorder: a cross-sectional observational structural MRI study.
    Schweren LJ; Hartman CA; Zwiers MP; Heslenfeld DJ; van der Meer D; Franke B; Oosterlaan J; Buitelaar JK; Hoekstra PJ
    Eur Child Adolesc Psychiatry; 2015 Aug; 24(8):959-68. PubMed ID: 25395383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug therapy in the treatment of minimal brain dysfunction.
    Saccar CL
    Am J Hosp Pharm; 1978 May; 35(5):544-52. PubMed ID: 26219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adolescent outcome of hyperactive children treated with stimulants in childhood: a review.
    Hechtman L
    Psychopharmacol Bull; 1985; 21(2):178-91. PubMed ID: 2860690
    [No Abstract]   [Full Text] [Related]  

  • 40. Aripiprazole induced acute dystonia after discontinuation of a stimulant medication.
    McLaren JL; Cauble S; Barnett RJ
    J Clin Psychopharmacol; 2010 Feb; 30(1):77-8. PubMed ID: 20075654
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.